Alembic Pharmaceuticals Limited (APLLTD) receives USFDA final approval for Ciprofloxacin and Dexamethasone Otic Suspension USP, expanding its generic drug po.
Lupin Limited (LUPIN) secures U.S. FDA approval for Modafinil Tablets, expanding its generics portfolio with a bioequivalent to Provigil®.
Lupin Limited (LUPIN) secures FDA approval for Sodium Zirconium Cyclosilicate Oral Suspension, expanding its therapeutic portfolio.
Dr. Reddy's Laboratories Ltd. (NSE: DRREDDY) receives FDA approval for its rituximab biosimilar, expanding its global biosimilars portfolio.
Lupin Limited (LUPIN) announces U.S. FDA approval and launch of Sugammadex Injection, a bioequivalent to Bridion®.
Alembic Pharmaceuticals Limited (APLLTD) secures USFDA final approval for Prucalopride Tablets, 1 mg and 2 mg, expanding its generic drug portfolio.
Glenmark Pharmaceuticals Limited (GLENMARK) secures U.S. FDA approval to expand RYALTRIS® use for children aged 6 to less than 12 years.
Alembic Pharmaceuticals Limited (APLLTD) announces USFDA final approval for Dapsone Gel, 5%, expanding its generic drug portfolio.
Aurobindo Pharma Limited (AUROPHARMA) secures final approval from US FDA for Tofacitinib Tablets, targeting a US$494 million market.
Wockhardt Limited (WOCKPHARMA) receives U.S. FDA approval for ZAYNICH™, a novel antibiotic for treating complicated urinary tract infections.